INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 33S33 trades$5.33M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

68,022 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
24
SD
Sykes DavidChief Commercial Officer
KLARKlarna Group plc
Option exercise
M—
238 sh
May 6, 2026Jul 1, 2026
traded May 6, 2026
+56dSEC Form 4

Evidence

24
SY
Shaer YaronChief Technology Officer
KLARKlarna Group plc
Option exercise
M—
48 sh
May 6, 2026Jul 1, 2026
traded May 6, 2026
+56dSEC Form 4

Evidence

24
GC
Giesecke CamillaChief Operating Officer
KLARKlarna Group plc
Option exercise
M—
41 sh
May 6, 2026Jul 1, 2026
traded May 6, 2026
+56dSEC Form 4

Evidence

24
HC
Hunsinger T. CharlesChief Information Officer
SVVSavers Value Village, Inc.
Option exercise
M$207K
20.3K sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

22
BH
Blumenthal Neil HarrisDirector, Co-Chief Executive Officer
WRBYWarby Parker Inc.
Open-market sale · 10b5-1 plan
SELL$1.09M
36.3K sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

21
CS
Cohen StephanieDirector
FISVFISERV INC
Grant or award
A$33K
663 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

21
SD
Sandstrom DavidChief Marketing Officer
KLARKlarna Group plc
Grant or award
A—
13.7K sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

21
BS
Bowser Douglas SDirector
HASHASBRO, INC.
Grant or award
A$35K
419 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

21
SY
Shaer YaronChief Technology Officer
KLARKlarna Group plc
Grant or award
A—
13.7K sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

21
CS
Casey SaoriDirector
APPFAPPFOLIO INC
Grant or award
A—
1,110 sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

21
KH
King Wen-Herng HenryDirector
CVCapsoVision, Inc
Option exercise
M—
2,022 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

21
WA
Weber AndrewEVP, Technology and Operations
WLYWLYBJOHN WILEY & SONS, INC.
Option exercise
M—
6,631 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

21
RC
Rogers Matthew CDirector
EXCEXELON CORP
Grant or award
A$36K
778 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

21
AN
Ahuja NitaDirector
ABTABBOTT LABORATORIES
Grant or award
A$31K
347 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

21
HM
Harari MicheleDirector
CVCapsoVision, Inc
Option exercise
M—
2,022 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

21
IC
Imperial Joanne CarolDirector
CVCapsoVision, Inc
Option exercise
M$15K
2,022 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

21
BP
Bhalla Narinder PalChief Medical Officer
LXEOLexeo Therapeutics, Inc.
Grant or award
A—
55.0K sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

21
PD
Paul Josh D.Chief Accounting Officer
PANWPalo Alto Networks Inc
Open-market sale · 10b5-1 plan
SELL$311K
900 sh
Jul 1, 2026Jul 1, 2026
traded Jul 1, 2026
+0dSEC Form 4

Evidence

21
IC
Imperial Joanne CarolDirector
CVCapsoVision, Inc
Option exercise
M—
2,022 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

21
BB
Brewer BradyDirector
GAPGAP INC
Grant or award
A—
9,903 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

21
BF
Barone FrancescaChief Scientific Officer
CADLCandel Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$236K
23.4K sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

21
WM
Wesolowski John MPrincipal Accounting Officer
INTSINTENSITY THERAPEUTICS, INC.
Grant or award
A$13K
3,688 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

21
MB
McGee Grant BExecutive Officer
TGTTARGET CORP
Grant or award
A—
15.3K sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

21
KY
Kuo Hui YingDirector
CVCapsoVision, Inc
Option exercise
M—
2,022 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

20
EB
Evans BronwynDirector
NONENONEEBR Systems, Inc.
In-the-money exercise
X$105K
27.6K sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

20
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Open-market sale
SELL$552K
26.6K sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

20
WA
Weber AndrewEVP, Technology and Operations
WLYWLYBJOHN WILEY & SONS, INC.
Tax withholding
F$202K
4,168 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

19
TR
ten Bosch John RoderickSVP of Laboratory Operations
BLLNBillionToOne, Inc.
Open-market sale · 10b5-1 plan
SELL$170K
1,416 sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

19
GC
Giesecke CamillaChief Operating Officer
KLARKlarna Group plc
Grant or award
A—
84.0K sh
Jun 1, 2026Jul 1, 2026
traded Jun 1, 2026
+30dSEC Form 4

Evidence

18
KS
Khanuja Parvinderjit S.Director
SEMSELECT MEDICAL HOLDINGS CORP
Disposition to issuer
D$1.31M
79.1K sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

17
VJ
VanBelle JenniferDirector
LLOEWS CORP
Grant or award
A—
223 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

17
KM
Khalid MuhammadEVP, Chief Operating Officer
DRVNDriven Brands Holdings Inc.
Grant or award
A—
54.9K sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

17
CA
Curry AngelaDirector
GABCGERMAN AMERICAN BANCORP, INC.
Grant or award
A—
1,168 sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

17
FR
Fondell RebeccaSVP & Chief Accounting Officer
DRVNDriven Brands Holdings Inc.
Grant or award
A—
12.2K sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

17
BE
Bothwick Jay EDirector
CNXNPC CONNECTION INC
Option exercise
M—
1,250 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

17
PJ
Pangburn Brian JamesVP, Controller and PAO
DPZDOMINOS PIZZA INC
Grant or award
A—
277 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

17
MW
McClintock WilliamDirector
IDAIT Stamp Inc
Grant or award
A—
52 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

17
TS
Tyagarajan SeshuChief Technology Officer
CADLCandel Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$70K
7,000 sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

16
GC
Gencer CigdemDirector
BMRCBank of Marin Bancorp
Other acquisition or disposition
J$25K
849 sh
Jul 1, 2026Jul 1, 2026
traded Jul 1, 2026
+0dSEC Form 4

Evidence

16
HC
Hunsinger T. CharlesChief Information Officer
SVVSavers Value Village, Inc.
Tax withholding
F$58K
5,663 sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

Page 574 of 1701
← PrevNext →